Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-019820

Chief Executive Officer sold 10,916 shares at an average $26.11 ($285,071)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-01-20 Sale 10b5-1 −5,833 $26.12 $152,333 562,080 D
Ceesay Abraham Chief Executive Officer 2026-01-20 Sale 10b5-1 −5,083 $26.11 $132,737 25,812 I
Open-market sales · 10,916 sh · avg $26.11 · $285,071
Loading xslF345X05/ownership.xml…